Page last updated: 2024-08-22

sulfadoxine and Brain Inflammation

sulfadoxine has been researched along with Brain Inflammation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboulker, JP; Azihary, M; Carbon, C; Charreau, I; Oksenhendler, E; Tournerie, C1
Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H1
Fukutomi, Y; Goto, H; Hara, T; Moriwaki, H; Murakami, N; Tajika, M; Tsurumi, H; Yoshimura, K1
Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T1
Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B1

Other Studies

5 other study(ies) available for sulfadoxine and Brain Inflammation

ArticleYear
Toxoplasma gondii infection in advanced HIV infection.
    AIDS (London, England), 1994, Volume: 8, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Encephalitis; Female; Humans; Male; Middle Aged; Pyrimethamine; Sulfadiazine; Sulfadoxine; Survival Rate; Toxoplasmosis; Toxoplasmosis, Cerebral; Trimethoprim, Sulfamethoxazole Drug Combination

1994
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Administration Schedule; Drug Combinations; Drug Hypersensitivity; Encephalitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Toxoplasmosis, Cerebral

1993
[Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Combinations; Encephalitis; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Pyrimethamine; Remission Induction; Sulfadoxine; Toxoplasmosis, Cerebral; Vincristine

1999
Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    The Journal of infection, 2001, Volume: 42, Issue:1

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cohort Studies; Drug Combinations; Drug Evaluation; Drug Hypersensitivity; Encephalitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Pneumonia, Pneumocystis; Prospective Studies; Pyrimethamine; Safety; Secondary Prevention; Sulfadoxine; Toxoplasmosis, Cerebral

2001
Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
    The Clinical investigator, 1992, Volume: 70, Issue:6

    Topics: Adult; Aerosols; Aged; CD4-Positive T-Lymphocytes; Drug Combinations; Encephalitis; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Primary Prevention; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Cerebral

1992